The class II histone deacetylase HDAC4 regulates cognitive, metabolic and endocrine functions through its expression in osteoblasts

Molecular Metabolism

Volumn 4, Issue 1, 2015, Pages 64-69

  Makinistoglu, Munevver Parla ^a   Karsenty, Gerard ^a  

^a Department of Genetics and Development Columbia University ^*  (United States)

Author keywords

Appetite; Cognition; Endocrine functions; HDAC4; Osteoblasts

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; HISTONE DEACETYLASE 4; INSULIN; OSTEOCALCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APPETITE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; INSULIN RELEASE; MALE; MALE FERTILITY; MEMORY; MOUSE; NONHUMAN; OSTEOBLAST; SPATIAL LEARNING; TRANSCRIPTION REGULATION;

EID: 84920748075     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2014.10.004     Document Type: Article

References (32)

1. Fukumoto S., Yamashita T. FGF23 is a hormone-regulating phosphate metabolism-Unique biological characteristics of FGF23. Bone 2007, 40:1190-1195. 10.1016/j.bone.2006.12.062.
2. Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:6500-6505. 10.1073/pnas.101545198.
3. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469. 10.1016/j.cell.2007.05.047.
4. Oury F., Sumara G., Sumara O., Ferron M., Chang H., Smith C.E., et al. Endocrine regulation of male fertility by the skeleton. Cell 2011, 144:796-809. 10.1016/j.cell.2011.02.004.
5. Oury F., Khrimian L., Denny C.A., Gardin A., Chamouni A., Goeden N., et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell 2013, 155:228-241. 10.1016/j.cell.2013.08.042.
6. Ferron M., Wei J., Yoshizawa T., Del Fattore A., DePinho R.A., Teti A., et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010, 142:296-308. 10.1016/j.cell.2010.06.003.
7. Karsenty G., Oury F. Biology without walls: the novel endocrinology of bone. Annual Review of Physiology 2012, 74:87-105. 10.1146/annurev-physiol-020911-153233.
8. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
9. Ducy P., Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Molecular and Cellular Biology 1995, 15:1858-1869.
10. Yang X., Matsuda K., Bialek P., Jacquot S., Masuoka H.C., Schinke T., et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 2004, 117:387-398.
11. Rached M.-T., Kode A., Silva B.C., Jung D.Y., Gray S., Ong H., et al. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. Journal of Clinical Investigation 2010, 120:357-368. 10.1172/JCI39901.
12. Bozec A., Bakiri L., Jimenez M., Schinke T., Amling M., Wagner E.F. Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production. Journal of Cell Biology 2010, 190:1093-1106. 10.1083/jcb.201002111.
13. Yoshizawa T., Hinoi E., Jung D.Y., Kajimura D., Ferron M., Seo J., et al. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. Journal of Clinical Investigation 2009, 119:2807-2817. 10.1172/JCI39366.
14. Kode A., Mosialou I., Silva B.C., Joshi S., Ferron M., Rached M.-T., et al. FoxO1 protein cooperates with ATF4 protein in osteoblasts to control glucose homeostasis. Journal of Biological Chemistry 2012, 287:8757-8768. 10.1074/jbc.M111.282897.
15. Bozec A., Bakiri L., Jimenez M., Rosen E.D., Catalá-Lehnen P., Schinke T., et al. Osteoblast-specific expression of Fra-2/AP-1 controls adiponectin and osteocalcin expression and affects metabolism. Journal of Cell Science 2013, 126:5432-5440. 10.1242/jcs.134510.
16. Verdin E., Dequiedt F., Kasler H.G. Class II histone deacetylases: versatile regulators. Trends in Genetics 2003, 19:286-293. 10.1016/S0168-9525(03)00073-8.
17. Haberland M., Montgomery R.L., Olson E.N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nature Reviews Genetics 2009, 10:32-42. 10.1038/nrg2485.
18. Berger S.L. Histone modifications in transcriptional regulation. Current Opinion in Genetics & Development 2002, 12:142-148.
19. Yang X.-J., Grégoire S. Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Molecular and Cellular Biology 2005, 25:2873-2884. 10.1128/MCB.25.8.2873-2884.2005.
20. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080. 10.1126/science.1063127.
21. Schreiber S.L., Bernstein B.E. Signaling network model of chromatin. Cell 2002, 111:771-778.
22. Obri A., Makinistoglu M.P., Zhang H., Karsenty G. HDAC4 integrates PTH and sympathetic signaling in osteoblasts. Journal of Cell Biology 2014, 10.1083/jcb.201403138.
23. Yoshikawa Y., Kode A., Xu L., Mosialou I., Silva B.C., Ferron M., et al. Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism. Journal of Bone and Mineral Research 2011, 26:2012-2025. 10.1002/jbmr.417.
24. Hinoi E., Gao N., Jung D.Y., Yadav V., Yoshizawa T., Myers M.G.J., et al. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. Journal of Cell Biology 2008, 183:1235-1242. 10.1083/jcb.200809113.
25. Drucker D.J., Philippe J., Mojsov S., Chick W.L., Habener J.F. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proceedings of the National Academy of Sciences of the United States of America 1987, 84:3434-3438.
26. Kreymann B., Williams G., Ghatei M.A., Bloom S.R. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987, 2:1300-1304.
27. Vega R.B., Matsuda K., Oh J., Barbosa A.C., Yang X., Meadows E., et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004, 119:555-566. 10.1016/j.cell.2004.10.024.
28. Potthoff M.J., Wu H., Arnold M.A., Shelton J.M., Backs J., McAnally J., et al. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. Journal of Clinical Investigation 2007, 117:2459-2467. 10.1172/JCI31960.
29. Rauch A., Seitz S., Baschant U., Schilling A.F., Illing A., Stride B., et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metabolism 2010, 11:517-531. 10.1016/j.cmet.2010.05.005.
30. Chang S., McKinsey T.A., Zhang C.L., Richardson J.A., Hill J.A., Olson E.N. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Molecular and Cellular Biology 2004, 24:8467-8476. 10.1128/MCB.24.19.8467-8476.2004.
31. Dakhova O., O'Day D., Kinet N., Yucer N., Wiese M., Shetty G., et al. Dickkopf-like1 regulates postpubertal spermatocyte apoptosis and testosterone production. Endocrinology 2009, 150:404-412. 10.1210/en.2008-0673.
32. Ferron M., Wei J., Yoshizawa T., Ducy P., Karsenty G. An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochemical and Biophysical Research Communications 2010, 397:691-696. 10.1016/j.bbrc.2010.06.008.